TABLE 2.
Information needs identified by stakeholder group
| Information needs | P | FM | HP | NGO |
|---|---|---|---|---|
| How/where to access the vaccine? | X | X | X | X |
| Are cancer patients a priority for vaccination/when will they be eligible for vaccination? | X | X | X | |
| What is the risk of having the vaccine versus risk of getting COVID at an individual level? | X | X | X | |
| What is the risk of side effects (especially blood clots as a cancer patient)? | X | X | X | X |
| What are the experiences of my peers with vaccine? Wait till confirmed safe… | X | X | X | |
| How will a weakened immune system respond to the vaccine? | X | X | ||
| How effective is the vaccine for cancer patients? | X | X | ||
| When in treatment cycle to get vaccinated/will it delay treatment/how long will I need to wait after treatment? | X | X | X | |
| What sort of long‐term/different mutation protection will the vaccine provide? | X | X | ||
| Will cancer patients need a vaccination to access support programs? | X |
Abbreviations: FM, family member; HP, health professional; NGO, nongovernment organization; P, patient.